Noncoding RNAs implication in cardiovascular diseases in the COVID-19 era

S. Greco, A. Madè, C. Gaetano, Y. Devaux, C. Emanueli, F. Martelli*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

13 Citations (Scopus)


COronaVIrus Disease 19 (COVID-19) is caused by the infection of the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2). Although the main clinical manifestations of COVID-19 are respiratory, many patients also display acute myocardial injury and chronic damage to the cardiovascular system. Understanding both direct and indirect damage caused to the heart and the vascular system by SARS-CoV-2 infection is necessary to identify optimal clinical care strategies. The homeostasis of the cardiovascular system requires a tight regulation of the gene expression, which is controlled by multiple types of RNA molecules, including RNA encoding proteins (messenger RNAs) (mRNAs) and those lacking protein-coding potential, the noncoding-RNAs. In the last few years, dysregulation of noncoding-RNAs has emerged as a crucial component in the pathophysiology of virtually all cardiovascular diseases. Here we will discuss the potential role of noncoding RNAs in COVID-19 disease mechanisms and their possible use as biomarkers of clinical use.

Original languageEnglish
Article number408
JournalJournal of Translational Medicine
Issue number1
Publication statusPublished - 1 Dec 2020


  • COVID-19
  • Cardiovascular disease
  • Noncoding RNAs
  • SARS-CoV-2
  • Transcriptomics


Dive into the research topics of 'Noncoding RNAs implication in cardiovascular diseases in the COVID-19 era'. Together they form a unique fingerprint.

Cite this